Lv11
48 积分 2022-08-17 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
6小时前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
6小时前
已完结
Individualized mRNA cancer vaccines make strides
9天前
已完结
Posters (Abstracts 301–2389)
16天前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
1个月前
已完结
M1/M4 receptors as potential therapeutic treatments for schizophrenia: A comprehensive study
2个月前
已完结
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study
2个月前
已完结
Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes
3个月前
已完结
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
4个月前
已完结
皖公网安备34019202002308
